Articles from BlinkRx

BlinkRx Welcomes Former U.S. Senator Joe Manchin, Healthcare Executive Heather Manchin, as Senior Advisors
BlinkRx, the leading digital health company transforming access to prescription medications, today announced that former U.S. Senator Joe Manchin has joined the company as a Senior Advisor. BlinkRx also announced that Heather Manchin, a seasoned healthcare executive and former CEO of Mylan, will serve alongside him as a Senior Advisor.
By BlinkRx · Via Business Wire · February 5, 2026
BlinkRx Welcomes Former Congressman Cedric Richmond as Senior Advisor
BlinkRx, the leading digital health company transforming access to prescription medications, today announced that former Congressman Cedric Richmond (D-LA) has joined BlinkRx as a Senior Advisor.
By BlinkRx · Via Business Wire · January 28, 2026
NeuroVice Prescription Device for Seizure Oral Injury Protection Now Available at BlinkRx
BlinkRx, the industry’s leading prescription journey management platform, announced that the PATI (Protector Against Tongue Injury) device from NeuroVice is now available on the BlinkRx platform. Through BlinkRx, patients and caregivers can access the lowest available pricing, free home delivery, and personalized support for PATI.
By BlinkRx · Via Business Wire · January 20, 2026
BlinkRx Launches “Operation Access Now” to Accelerate and Scale Direct‑to‑Patient and Direct‑to‑Business Programs
BlinkRx, the nation's leading prescription lifecycle management platform, today announced the launch of Operation Access Now, a rapid deployment initiative that enables pharmaceutical manufacturers to build and launch direct-to-patient (DTP) and direct‑to‑business (DTB) channels that expand medication access and deliver pricing transparency in as little as 21 days.
By BlinkRx · Via Business Wire · August 7, 2025
BlinkRx is Now Offering neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
BlinkRx, the world’s most advanced patient access platform for branded medications, is excited to announce a new partnership with ARS Pharmaceuticals to offer neffy®, the needle-free epinephrine nasal spray, now available on its platform. neffy is the first and only needle-free treatment for severe allergic reactions, including life-threatening anaphylaxis for children and adults who weigh 30kgs (66lbs.) or more. Now, prescribed patients can conveniently access neffy through the BlinkRx platform, a service that provides patients transparent prices, free home delivery, and personalized, concierge-level support.
By BlinkRx · Via Business Wire · October 7, 2024
Articles from BlinkRx | MarketMinute